Revvity Inc (RVTY)
100.61
-0.47
(-0.46%)
USD |
NYSE |
May 03, 16:00
100.56
-0.05
(-0.05%)
Pre-Market: 20:00
Revvity Gross Profit (TTM): 1.513B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.513B |
December 31, 2023 | 1.540B |
September 30, 2023 | 1.593B |
June 30, 2023 | 1.627B |
March 31, 2023 | 1.776B |
December 31, 2022 | 1.990B |
September 30, 2022 | 2.197B |
June 30, 2022 | 2.313B |
March 31, 2022 | 2.447B |
December 31, 2021 | 2.637B |
September 30, 2021 | 2.441B |
June 30, 2021 | 2.445B |
March 31, 2021 | 2.207B |
December 31, 2020 | 1.730B |
September 30, 2020 | 1.681B |
June 30, 2020 | 1.496B |
March 31, 2020 | 1.396B |
December 31, 2019 | 1.396B |
September 30, 2019 | 1.374B |
June 30, 2019 | 1.364B |
March 31, 2019 | 1.357B |
December 31, 2018 | 1.341B |
September 30, 2018 | 1.272B |
June 30, 2018 | 1.209B |
March 31, 2018 | 1.126B |
Date | Value |
---|---|
December 31, 2017 | 1.074B |
September 30, 2017 | 1.043B |
June 30, 2017 | 1.023B |
March 31, 2017 | 1.019B |
December 31, 2016 | 1.014B |
September 30, 2016 | 958.93M |
June 30, 2016 | 964.98M |
March 31, 2016 | 963.94M |
December 31, 2015 | 964.23M |
September 30, 2015 | 950.08M |
June 30, 2015 | 938.79M |
March 31, 2015 | 934.26M |
December 31, 2014 | 934.60M |
September 30, 2014 | 1.004B |
June 30, 2014 | 993.74M |
March 31, 2014 | 987.41M |
December 31, 2013 | 976.58M |
September 30, 2013 | 959.80M |
June 30, 2013 | 957.27M |
March 31, 2013 | 954.40M |
December 31, 2012 | 961.53M |
September 30, 2012 | 940.49M |
June 30, 2012 | 909.10M |
March 31, 2012 | 879.50M |
December 31, 2011 | 847.80M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.364B
Minimum
Jun 2019
2.637B
Maximum
Dec 2021
1.858B
Average
1.706B
Median
Gross Profit (TTM) Benchmarks
Agilent Technologies Inc | 3.405B |
Bruker Corp | 1.506B |
Azenta Inc | 250.79M |
Harvard Bioscience Inc | 66.07M |
Bionano Genomics Inc | 9.565M |